Pratibha Sudhir Pilgaonkar
Patrimonio netto: 109 M $ in data 30/09/2026
Patrimonio netto: 109 M $ in data 30/09/2026
Pratibha Sudhir Pilgaonkar is the founder of Rubicon Research Ltd., founded in 1999, holding the titles of Executive Director and Managing Director since 2019.
Former jobs include Vice President-Product Development at Sun Pharmaceutical Industries Ltd. and Head-Product Development at Novartis India Ltd. Education history includes undergraduate and graduate degrees from the University of Mumbai in 1977 and 1978 respectively, and an undergraduate degree from the University Institute of Chemical Technology in 1977.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/10/2025 | 6.435.000 ( 3,89% ) | 109 M $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RUBICON RESEARCH LIMITED | Fondatore | 06/05/1999 |
| Società | Posizione | Fine |
|---|---|---|
| EVONILE PHARMA LIMITED | Corporate Officer/Principal | - |
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical ingredients | Health Technology |
Novartis India Ltd.
Novartis India Ltd. Pharmaceuticals: MajorHealth Technology Engages in the pharmaceuticals, generics, over-the-counter and animal health businesses | Health Technology |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University Institute of Chemical Technology
University Institute of Chemical Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rubicon Research Ltd.
Rubicon Research Ltd. BiotechnologyHealth Technology Engages in research, development and production of pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale